SARS-CoV-2 Antigen Rapid Qualitative Test Type A

Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

TT3 is the main hormone that thyroid hormone does to various target organs. The serum TT3 concentration reflects the thyroid gland’s ability to function better than the thyroid gland. TT3 is an important indicator of early hyperthyroidism and the monitoring of recurrent hyperthyroidism and pseudo thyrotoxicosis.

TheCMV IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies toCMV in human serum. IgG results with this assay are used to indicate past or recent infection with CMV. IgM results obtained with this assay are used as an aid in the diagnosis of acute or recent CMV infections. CMV IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Cytomegalovirus (CMV) infection -For in vitro diagnostic use only. For professional use only.

Hepatitis C is a liver disease caused by the hepatitis C virus (HCV): the virus can cause both acute and chronic hepatitis, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis C is a major cause of liver cancer.

HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Glycated hemoglobin A1c (HbA1c) concentration in human whole blood that contains EDTA or without anticoagulants samples, mainly used for the supervising of long-term glycemic control in diabetic individuals and auxiliary diagnosis of diabetes and identify patients at risk of diabetes.

CRP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-reactive proteins (CRP) concentration in human serum, plasma and vein whole blood specimens.

The HSV-2 IgG/IgM Rapid Test is an in vitro immunoassay for the qualitative determination of IgG and IgM class antibodies to HSV2 in human serum. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection. The HSV-2 IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Herpes simplex viruses2 (HSV-2) infection -For in vitro diagnostic use only. For professional use only.